Ahead of "You Can See Everything" hitting theaters, let's rewind the last decade and review some of the most significant news ...

At the STAT Summit, the Department of Justice offered up a warning for health care executives: Don’t be another Theranos.

Following a green light from the FDA, European regulators have now recommended the approval of Revolution Medicines' Rasonque for pancreatic cancer.

Changes to the annual performance review process are the latest flashpoint in tensions between federal workers across the ...

In mental health care, I encountered people who believed that medication changed who they were. They didn’t mean the common ...

Rep. Jake Auchincloss (D-Mass.) has some advice for fellow lawmakers: unapologetically support the biotech industry.

The Trump administration is proceeding with a plan to allow compounding pharmacies to produce certain peptides ...

Scott Gottlieb, and Ned Sharpless (both from the first Trump administration) criticized the officials who ran the agency ...

A jury awarded $6 million in damages to scientist David Sabatini, whose career imploded after he was accused by a much younger colleague of inappropriate sexual conduct in his lab.

Helen Branswell covers issues broadly related to infectious diseases, including outbreaks, preparedness, research, and vaccine development. Follow her on Mastodon and Bluesky. You can reach Helen on ...

Stephen Hoge and Dean Li, at the STAT Summit, spoke of how Merck and Moderna will pair Keytruda with personalized mRNA ...

U.S. health officials are moving ahead with a plan to allow specialty pharmacies to produce certain peptides, a class of ...